Edition:
India

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

5.53USD
1:00am IST
Change (% chg)

$-0.06 (-1.07%)
Prev Close
$5.59
Open
$5.58
Day's High
$5.58
Day's Low
$5.31
Volume
1,763
Avg. Vol
5,363
52-wk High
$11.65
52-wk Low
$5.31

Latest Key Developments (Source: Significant Developments)

Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope
Saturday, 24 Feb 2018 

Feb 23 (Reuters) - Iridex Corp ::IRIDEX ISSUES VOLUNTARY RECALL OF TRUFOCUS LIO PREMIERE™ LASER INDIRECT OPHTHALMOSCOPE.IRIDEX CORP - REVISED ITS PRELIMINARY FINANCIAL RESULTS FOR Q4 AND FULL YEAR ENDED DECEMBER 30, 2017.IRIDEX CORP - RECALLED PRODUCTS WERE MANUFACTURED FROM MAY 26, 2017 TO NOVEMBER 6, 2017 AND DISTRIBUTED FROM JUNE 5, 2017 TO JANUARY 29, 2018.IRIDEX CORP - TOTAL REVENUE FOR Q4 OF 2017 IS EXPECTED TO BE $10.2 TO $10.3 MILLION.IRIDEX CORP - TOTAL REVENUE FOR 2017 IS EXPECTED TO BE $41.5 TO $41.6 MILLION.IRIDEX CORP - COMPANY HAS RECEIVED REPORTS OF THREE ADVERSE EVENTS OCCURRING DURING PROCEDURES IN WHICH TRUFOCUS LIO PREMIERE WAS USED.  Full Article

Societe Quantel Issues Response To Iridex Press Release​
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Societe Quantel Sa ::‍QUANTEL ISSUES RESPONSE TO IRIDEX PRESS RELEASE​.‍WE DO NOT ANTICIPATE ANY DISRUPTION TO OUR ONGOING COMMERCIAL PROGRESS​.SAYS BELIEVES ‍IRIDEX'S ACTION IS WITHOUT MERIT​.‍QUANTEL INTENDS TO VIGOROUSLY DEFEND ITSELF AGAINST CLAIMS​.  Full Article

Iridex Corp ‍Filed Lawsuit Against Quantel Medical S.A
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Iridex Corp ::IRIDEX CORP - ‍FILED LAWSUIT AGAINST QUANTEL MEDICAL S.A., QUANTEL USA, QUANTEL, S.A. IN U.S. DISTRICT COURT FOR NORTHERN DISTRICT OF CALIFORNIA​.  Full Article

Iridex Corp reports qtrly loss per share $0.27‍​
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Iridex Corp :Iridex announces 2017 third quarter financial results.Q3 revenue rose 11 percent to $10.9 million.Iridex Corp - ‍Iridex reiterates its previously provided estimate for revenue, and g6 system and g6 probe shipments for full year 2017​.Iridex Corp - qtrly loss per share $0.27‍​.  Full Article

Iridex Q3 preliminary revenues of approximately $9.6 to $9.7 mln
Wednesday, 12 Oct 2016 

Iridex Corp : Iridex announces preliminary revenues for 2016 third quarter . Preliminary revenues of approximately $9.6 to $9.7 million for q3 ended october 1, 2016 . Iridex - while demand for Cyclo G6 laser platform for glaucoma remained strong, revenues of certain retina products were below expectations ."demand for company's new flagship Cyclo G6 laser platform for glaucoma remained strong".  Full Article

Iridex sees Q3 revenue $11 million to $11.3 million
Friday, 5 Aug 2016 

Iridex Corp : Q2 loss per share $0.03 . Q2 revenue rose 32 percent to $11.9 million . Month results . Sees Q3 2016 revenue $11 million to $11.3 million . Company continues to expect revenue growth for full year 2016 to be in low double-digits .Expect higher revenue in q4 relative to q3 due to typical seasonality.  Full Article

BRIEF-Iridex Announces Availability Of G-Probe Illuminate Device In Europe

* IRIDEX CORP - AVAILABILITY OF G-PROBE ILLUMINATE DEVICE IN EUROPE Source text for Eikon: Further company coverage: